American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (988)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (941)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1257)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (312)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (64)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5174)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5555)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Increased bone marrow plasma cells at diagnosis predicts overall mortality in AL amyloidosis patients undergoing risk-adapted stem cell transplant
    Meeting Abstract

    Landry, C. A.; Smith, M.; Chou, J. F.; Devlin, S. M.; Hassoun, H.; Bello, C.; Landgren, O.; Giralt, S.; Comenzo, R. L.; Landau, H.
    Blood (2014)

    Fulltext@MSK | Save
  • Carfilzomib, lenalidomide, and dexamethasone in high-risk smoldering multiple myeloma: Final results from the NCI phase 2 pilot study
    Meeting Abstract

    Landgren, O.; Roschewski, M.; Mailankody, S.; Kwok, M.; Manasanch, E. E.; Bhutani, M.; Tageja, N.; Kazandjian, D.; Zingone, A.; Costello, R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • A comparison of human CMVpp65-specific central memory and effector memory CD8 T-cells when stimulated in-vivo with IL-2 or IL-15/IL-15R alpha complex in a murine xenograft model of adoptive cell therapy
    Meeting Abstract

    Kuo, T. Y.; Hasan, A.; O'Reilly, R. J.
    Blood (2014)

    Fulltext@MSK | Save
  • Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Yahalom, J.; Schoder, H.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; Hamilton, A.; Hamlin, P.; Horwitz, S. M.; Jacob, A. G.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Issues in categorization and management of pediatric patients with myeloproliferative neoplasms
    Meeting Abstract

    Kucine, N.; Levine, R. L.; Bussel, J. B.
    Blood (2014)

    Fulltext@MSK | Save
  • Patient derived xenograft (PDX) models recapitulate the genomic-driver composition of acute leukemia samples
    Meeting Abstract

    Krivtsov, A. V.; Wang, X. J.; Farnoud, N. R.; Hadler, M.; Martin, M. S.; Knapp, K. M.; Stein, E. M.; Lipson, D.; Nahas, M. K.; Stephens, P. J.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Immunoglobulin variable region family usage and outcomes of patients with systemic light chain amyloidosis
    Meeting Abstract

    Kourelis, T.; Dasari, S.; Kurtin, P. J.; Ramirez-Alvarado, M.; Zeldenrust, S. R.; Theis, J. D.; Gertz, M. A.; Dogan, A.; Dispenzieri, A.
    Blood (2014)

    Fulltext@MSK | Save
  • Minimal residual disease (MRD) testing in newly diagnosed multiple myeloma (MM) patients: A prospective head-to-head assessment of cell-based, molecular, and molecular-imaging modalities
    Meeting Abstract

    Korde, N.; Mailankody, S.; Roschewski, M.; Faham, M.; Kotwaliwale, C.; Moorhead, M.; Kwok, M. L.; Manasanch, E. E.; Bhutani, M.; Tageja, N.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Series of hairy cell leukemia patients with co-existent plasma cell disorders
    Meeting Abstract

    Korde, N.; Mailankody, S.; Arons, E.; Braylan, R. C.; Raffeld, M.; Maestri, E.; Yuan, C.; Stetler-Stevenson, M.; Landgren, O.; Maric, I.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Biomarker proteasome levels predict response to combination therapy with carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Korde, N.; Dosani, T.; Simakova, O.; Mailankody, S.; Costello, R.; Roschewski, M.; Yuan, C.; Stetler-Stevenson, M.; Figg, W. D.; Landgren, O.; more...
    Blood (2014)

    Fulltext@MSK | Save